 Business Standard | Glenmark signs licensing deal mydigitalfc.com This marks Glenmark's global entry into high-end anti-ageing cosmeceutical care segment. Arvind Vasudeva, chief operating officer, Glenmark Pharmaceuticals, said in a statement, “There is significant need for these high-end products across our ... Glenmark Pharmaceuticals enters into exclusive agreement with Immanence-IDC |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.